In addition, CD19 and CD20 surface expression were determined on a comprehensive panel of 21 DLBCL and 7 BL cell lines to investigate whether these cell lines represent adequate models for functional in vitro and in vivo assays. This evidence concerns the gene CD19 and diffuse large B-cell lymphoma.